ACADIA Pharmaceuticals, Inc. (ACAD)
28.02
+0.16
(+0.57%)
USD |
NASDAQ |
Sep 04, 16:00
28.01
-0.01
(-0.04%)
After-Hours: 20:00
ACADIA Pharmaceuticals SG&A Expense (TTM) : 620.29M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 620.29M |
| March 31, 2026 | 593.54M |
| December 31, 2025 | 548.89M |
| September 30, 2025 | 523.36M |
| June 30, 2025 | 523.25M |
| March 31, 2025 | 506.81M |
| December 31, 2024 | 488.43M |
| September 30, 2024 | 469.81M |
| June 30, 2024 | 434.41M |
| March 31, 2024 | 413.31M |
| December 31, 2023 | 406.56M |
| September 30, 2023 | 399.50M |
| June 30, 2023 | 379.71M |
| March 31, 2023 | 373.65M |
| December 31, 2022 | 369.09M |
| September 30, 2022 | 370.46M |
| June 30, 2022 | 377.01M |
| March 31, 2022 | 386.58M |
| December 31, 2021 | 404.07M |
| September 30, 2021 | 419.05M |
| June 30, 2021 | 418.78M |
| March 31, 2021 | 406.23M |
| December 31, 2020 | 396.21M |
| September 30, 2020 | 367.33M |
| June 30, 2020 | 357.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 341.01M |
| December 31, 2019 | 331.58M |
| September 30, 2019 | 315.55M |
| June 30, 2019 | 303.20M |
| March 31, 2019 | 304.17M |
| December 31, 2018 | 271.71M |
| September 30, 2018 | 262.56M |
| June 30, 2018 | 262.19M |
| March 31, 2018 | 253.31M |
| December 31, 2017 | 256.80M |
| September 30, 2017 | 247.77M |
| June 30, 2017 | 236.05M |
| March 31, 2017 | 224.71M |
| December 31, 2016 | 186.46M |
| September 30, 2016 | 151.41M |
| June 30, 2016 | 121.18M |
| March 31, 2016 | 91.53M |
| December 31, 2015 | 88.30M |
| September 30, 2015 | 76.11M |
| June 30, 2015 | 63.86M |
| March 31, 2015 | 50.69M |
| December 31, 2014 | 32.75M |
| September 30, 2014 | 26.60M |
| June 30, 2014 | 22.34M |
| March 31, 2014 | 16.89M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Incyte Corp. | 1.399B |
| Agios Pharmaceuticals, Inc. | 192.74M |
| Biogen, Inc. | 2.594B |
| Insmed, Inc. | 893.58M |
| Arcutis Biotherapeutics, Inc. | 297.60M |